Matthew Hayes (Left) is the Chief Technology Officer and founder at Evonetix, a groundbreaking gene synthesis technology company created in 2015, where he deploys his expertise in multi-disciplinary ...
The commercial availability of an increasing diversity of enzymes has led to the growing use of biocatalysts for API synthesis. The complexity of both small-molecule and large-molecule drugs is ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results